25Oct/13

What's Behind AbbVie's Rocking Q3 Earnings – Motley Fool


Jutia Group

What’s Behind AbbVie’s Rocking Q3 Earnings
Motley Fool
AbbVie’s partnership with Biogen Idec (NASDAQ: BIIB ) on daclizumab also looks promising. The drug targets treatment of patients with relapsed or remitting multiple sclerosis. Daclizumab is currently in a late-stage study. AbbVie and Biogen expect that
AbbVie Inc (ABBV): AbbVie’s CEO Discusses Q3 2013 Results – Earnings Call Seeking Alpha
AbbVie Reports Third-Quarter 2013 Financial ResultsMarketWatch

all 25 news articles »

25Oct/13

High-Risk Organs From Deceased Donors Safe When Screened with Current … – Infection Control Today


Counsel & Heal

High-Risk Organs From Deceased Donors Safe When Screened with Current
Infection Control Today
Approximately 10 percent of deceased donor kidneys are considered “high-risk” for infection (HIV, HCV, HBV) and disease transmission according to criteria set by the Centers for Disease Control and Prevention. But new research suggests that many of
Some ‘High-Risk’ Kidneys May Be Safe for Organ Transplant: StudyHealthDay

all 4 news articles »

25Oct/13

'High-risk' organs from deceased donors safe when screened with current methods – Medical Xpress

‘High-risk’ organs from deceased donors safe when screened with current methods
Medical Xpress
Approximately 10% of deceased donor kidneys are considered “high-risk” for infection (HIV, HCV, HBV) and disease transmission according to criteria set by the Centers for Disease Control and Prevention. But new research suggests that many of these 

and more »

25Oct/13

'High-risk' organs from deceased donors safe when screened with current methods – ScienceBlog.com (blog)


Guardian Express

‘High-risk’ organs from deceased donors safe when screened with current methods
ScienceBlog.com (blog)
Approximately 10% of deceased donor kidneys are considered “high-risk” for infection (HIV, HCV, HBV) and disease transmission according to criteria set by the Centers for Disease Control and Prevention. But new research suggests that many of these 
Paying kidney donors is cost-effective, researchers sayFox News
Why Not Pay People To Become Kidney Donors?Science 2.0
$10000 for a Kidney? Study Says Paying for Organs Could Save Lives and MoneyTIME
HealthDay –CBC.ca –Everyday Health
all 16 news articles »
25Oct/13

Barcelona's Fabregas says Arsenal 'is in his heart' – Times of India


Times of India

Barcelona’s Fabregas says Arsenal ‘is in his heart
Times of India
LONDON: Barcelona midfielder Cesc Fabregas believes Arsenal are now looking strong enough to win the Premier League title for the first time since 2004 and he hopes they do because the club “is in my heart“. The Spain midfielder, who played 303 games 
Barcelona ace Fabregas says Arsenal, Premier League ‘still in his heartNewstrack India

all 74 news articles »